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Advances in breast imaging over the last 15 years have improved early breast cancer detection and management. After treatment for breast
cancer, many women choose to have reconstructive surgery. In addition, with the availability of widespread genetic screening for breast
cancer, an increasing number of women are choosing prophylactic mastectomies and subsequent breast reconstruction. The purpose of this
pictorial essay is to present the spectrum of imaging findings in the reconstructed breast.Resume
Les progres en mammographie au cours des 15 dernieres annees ont permis d’ameliorer le depistage et la gestion du cancer du sein.
De nombreuses femmes choisissent de subir une chirurgie de reconstruction mammaire a la suite d’un traitement du cancer du sein. En outre,
depuis que le depistage genetique est devenu une pratique repandue pour le cancer du sein, un nombre croissant de femmes optent pour une
mastectomie prophylactique suivie d’une reconstruction. Cet article descriptif vise a presenter la gamme de resultats d’imagerie du sein
reconstruit.
 2011 Canadian Association of Radiologists. All rights reserved.
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Breast reconstruction is an important component of breast
cancer treatment. Although breast conservation is suitable for
manybreast cancer patients, somewomen are recommended to
have or choose to undergo mastectomies either for oncologic
reasons or to avoid the anxiety associated with regular
surveillance. High satisfaction rates have been reported in
women after breast reconstruction [1,2]. The refinement of
surgical techniques for breast reconstruction has led to
improved outcomes and may influence a patient’s decision to
undergo a mastectomy instead of breast conservation surgery* Address for correspondence: Anabel M. Scaranelo, MD, PhD, 610
University Avenue, Room 3-922, Princess Margaret Hospital, Toronto,
Ontario M5G 2M9, Canada.
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doi:10.1016/j.carj.2010.09.010[3,4]. For example, the development of the skin sparing
mastectomy (SSM) has revolutionized autologous breast
reconstruction, and an excellent cosmetic result can be
achieved because of the preservation of the native breast skin,
which remains after themastectomy (Figure 1). This technique
allows for the maintenance of the crucial anatomic borders of
the breast and, therefore, has transformed breast reconstruc-
tion into a ‘‘filling’’ procedure rather than a more complicated
‘‘shaping’’ procedure [2e4]. Surgical techniques for breast
reconstruction can be divided into 3 groups: (1) implant-based
techniques; (2) autologous tissue-based techniques; and (3)
a combination of these 2 techniques.
Implant-based breast surgery has been available since the
early 1960s when Cronin and Gerow, 2 plastic surgeons from
Texas, developed the first silicone gel prosthesis [4]. Modern
implant-based breast reconstruction is usually a 2-stage process
whereby, at the time of a mastectomy, a tissue expander isll rights reserved.
Figure 1. Preoperative (A) and postoperative (B) images of an immediate, unilateral reconstructed breast with an excellent cosmetic result. The patient was
satisfied with both the reconstructed breast and the appearance of the abdomen.
Figure 2. Delayed reconstruction by using a deep inferior epigastric perforator (DIEP) flap. (A) Status post left mastectomy. (B) Status post left breast
reconstruction.
Figure 3. A patient who is a BRCA1mutation carrier and with bilateral reconstruction by using silicone implants. The left mastectomywas performed for invasive
ductal carcinoma and the right prophylactically. (A) Bilateral digital mammography, showing a high mammographic density because of the presence of implants.
Dynamic contrast-enhancement magnetic resonance imaging, showing the delayed phase axial T1-weighted images of both reconstructed breasts with double-
lumen, nonruptured implants (B).
61Imaging of the reconstructed breasts / Canadian Association of Radiologists Journal 62 (2011) 60e72inserted under the chest-wall muscle to create a space for the
final implant. The tissue expander is like a balloon and is filled,
through transcutaneous punctures, with saline solution during
follow-up clinic visits. Once the insufflations have created the
required space underneath the chest-wallmuscle, a final implant
(often silicone filled) is used to replace the tissue expander
during a secondoperation.This is usually performed3-6months
after the initial operation. More recent advances in breast
reconstruction have potentially minimized the need for
numerous operations. By using an allogeneic dermal substitute(Allo-Derm, Lifecell Corporation, Branchburg, NJ) to help
cover the implant, placement of the final implant can be per-
formed during the initial operation and the need for a tissue
expander may be omitted. The use of allogeneic dermal
substitutes is fairly newwithin the field of breast reconstruction,
and studies looking at outcomes are still in progress at our
Canadian tertiary hospital.
Over the last 10 years, autologous breast reconstruction has
also seen many advances. Autologous reconstruction tech-
niques commonly include abdominal-based flaps, such as
Figure 4. Normal digital mammographic appearance of a transverse rectus
abdominus myocutaneous (TRAM) flap. The patient had a left mastectomy
for breast malignancy in 1991. (A) Mediolateral oblique view, showing the
presence of metallic surgical clips in the upper posterior breast. (B) Cra-
niocaudal view, showing a completely fatty composition of the left recon-
structed breast.
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(TRAM) flaps, muscle sparing free TRAM flaps, deep inferior
epigastric perforator (DIEP) flaps, and superficial inferior
epigastric artery flaps. In addition, a variety of free flaps from
distant donor sites exist, including superior gluteal artery
perforator flaps and transverse upper gracilis flaps. Latissimus
dorsi flaps may also be used and generally require the addi-
tional use of an implant.
Since the 1980s, TRAMflaps have commonly been used for
breast reconstruction. Free TRAM flaps that use the deep
inferior epigastric vessels have better perfusion comparedwithFigure 5. Normal magnetic resonance imaging appearance of a deep inferior epi
showing an entirely fatty composition of the right breast. For comparison, note the
included on the left side to obtain symmetry. Mediolateral oblique (B) and cranio
Note also the presence of the soft-tissue density of the muscle flap with adjacen
breast.traditional pedicled TRAM flaps that use the deep superior
epigastric vessels. Therefore, free TRAM flaps potentially
have greater application in patients with increased risk of
complications, delayed wound healing, and partial flap loss,
such as those who smoke and those women who are obese as
well as patients who need adjuvant radiotherapy for local or
regional control of breast cancer [4-7]. However, abdominal-
based muscle sparing or muscle-preserving perforator
(eg, DIEP) flaps are becoming the criterion standard for
autologous breast reconstruction against which all forms of
breast reconstruction are measured in terms of safety and
esthetic outcome [1,2,5]. Donor-site preserving flap harvesting
techniques have been developed through an enhanced
appreciation of flap anatomy and physiology (Figure 2).
A variety of breast reconstruction options exist after
a mastectomy. Along with advances in reconstructive options,
a variety of new modalities exist for breast imaging. The
purpose of this review is to describe the mammographic,
sonographic, computed tomography (CT), and magnetic
resonance imaging (MRI) features in normal and abnormal
imaging examinations of reconstructed breasts.
Normal Imaging Features of a Reconstructed Breast
Several breast implant styles are typically offered for most
implant types by each manufacturer. An implant ‘‘style’’ is
typically characterized by a unique combination of basic
implant features, such as shape, shell, profile, and fixation.
Each style is usually offered in a range of sizes that may vary
from 70 mL to more than 1000 mL. Availability of special
order and custom implants further increases the number of
possible variations. A reconstructed breast with either silicone
or saline solution implants presents with a high mammo-
graphic density (Figure 3) if a dedicated technique to evaluategastric perforator (DIEP) flap. (A) Axial T1-weighted image of both breasts,
presence of normal glandular tissue in the left breast. A silicone implant was
caudal (C) digital mammograms, showing the low density of the right breast.
t surgical clips on both views in the upper inner aspect of the reconstructed
Figure 6. Computed tomographic (CT) appearance of a reconstructed
breast in a 72-year-old woman 13 years after left breast, unilateral
reconstruction with a pedicle transverse rectus abdominus myocutaneous
(TRAM) flap (A) and in a 55-year-old woman 3 years after unilateral left
breast reconstruction with pedicle TRAM flap (B). CT images, showing
greater fat attenuation in the reconstructed breasts compared with the
contralateral, nonreconstructed breasts. Different degrees of muscle flap
atrophy are seen.
Figure 7. A 31-year-old woman with a history of right breast, T2 invasive
ductal carcinoma and in situ duct carcinoma. This patient underwent a right
mastectomy and axillary node dissection followed by 5 months of chemo-
therapy and 25 sessions of radiotherapy. A latissimus dorsi myocutaneous flap
with tissue expanderwas used to reconstruct the right breast because the patient
had prior radiation. Digital mammography (A) and magnetic resonance
imaging, nonefat saturated, nonenhanced axial T1-weighted images (B),
showing a 410 LL 220-g weight silicone implant positioned under the pectoral
muscle cranially and under the latissimus dorsimuscle caudally and anteriorly.
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more radiodense than saline solution implants. Most saline
solutione and dextran-filled implants are inflated through
a valve at the time of surgery. The valve is not usually evident
on screen film mammography if an overpenetrated image is
not obtained, however, the valve can be easily identified in
full-field digital mammography (FFDM) by narrowing the
window on a digital workstation. In addition to the simple
single-lumen dextran- and saline solution-filled implants, all
tissue expanders have a valve, some of which havemore than 1
lumen. They have been manufactured in a wide variety of
shapes and sizes. Radiologists rarely see tissue expanders in
the course of breast implant evaluation, because they are
intended to be temporary devices and do not require straight-
forward imaging evaluation.Autologous flaps may present with the predominantly fatty
appearance of a ‘‘tummy tuck.’’ A posterior density may be
visualized if a muscle component is present. The variable
mammographic density of autologous flaps may be because of
postoperative scarring, and the identification has been linked
proportionally to increased surgical time. Other common
normal findings within a reconstructed breast include the
presence of a vascular pedicle and/or surgical clips [8e10].
The normal mammographic features of a TRAM flap are
shown in Figure 4, and Figure 5 shows the normal mammo-
graphic and MRI features of a DIEP flap.
Generally, it is not possible to differentiate among the
various types of autologous flaps by imaging alone without
prior knowledge of the patient’s surgical history becausemany
flaps have similar features on ultrasound, MRI, computed
Figure 8. Images of a palpable firm mass in a reconstructed breast with a transverse rectus abdominus myocutaneous (TRAM) flap. The digital mammography
mediolateral oblique view (A), with a radiopaque marker on the skin, showing a radiolucent small mass (arrows). Targeted ultrasound (B), showing a cir-
cumscribed, hypoechoic, superficial mass.
Figure 9. Digital mammography magnification view, demonstrating a macro-
calcification (arrow) and an area of punctatemicrocalcifications (arrowheads) in
a patient with an 8-year-old transverse rectus abdominus myocutaneous
(TRAM) flap.
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difficult to identify a TRAMflap because of the presence of the
atrophied rectus abdominis muscle along the anterior chest
wall may not be demonstrated mammographically because of
difficulties in positioning and variable reconstructed anatomy.
However, this feature can be easily demonstrated by either CT
or MRI (Figures 5, 6). On CT or MRI, a thin curvilinear line
that parallels the breast contour is sometimes seen, which
represents the epithelial layer of the lower abdominal tissue.
The radiographic density or signal intensity of attenuation of
the fat anterior to the epithelial layer represents the adipose
tissue of the native chest wall, whereas the tissue deep to it
represents the transposed abdominal wall fat [10,11].
A combination of implants and autologous tissue may be
used for cosmetic reasons. The imaging appearance of an
autogenous myocutaneous flap plus implant is similar to that
of a TRAM flap in a reconstructed breast after mastectomy
(Figure 7).
Benign Imaging Features of a Reconstructed Breast
A frequent complication after autologous breast recon-
struction is the presence of fat necrosis. Fat necrosis refers to an
area of firmness within adipose tissue that occurs after fat has
become devitalized. Although several theories exist, the exact
pathophysiology that leads to the formation of fat necrosis has
not yet been elucidated. Regardless of the cause, these firm
areas can alter the aesthetic result of the breast and can be
painful to the patient. Current literature reports a wide range in
the incidence of fat necrosis that varies, depending on the type
Figure 10. A 54-year-old patient treated with a right mastectomy in 2005, fol-
lowed by reconstruction with an autologous flap in 2007, and contralateral left
breast reduction in 2008. Digital mammography magnification views, demon-
strating bilateral benign calcifications: dystrophic calcifications in the posterior
aspect of the right reconstructed breast (A) and round isolated benign calcifi-
cations in the contralateral after mammoplasty of the left breast (B).
Figure 11. A 54-year-old woman with a history of left breast cancer who
underwent bilateral transverse rectus abdominus myocutaneous (TRAM) flap
breast reconstruction.Apalpablemasswas appreciated in the left breast,which
sonographically corresponded to a cystic lesion (oil cyst) with thin walls.
Figure 12. A sonographic image, showing a complex cystic mass with thick
irregular walls in a woman who previously underwent a transverse rectus
abdominus myocutaneous (TRAM) flap. Fine needle aspiration was per-
formed proving fat necrosis.
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TRAM, 5.9%e12.9% for a free TRAM, and 6%e62.5% for
a DIEP flap) [6,7,12,13].
It is important to be able to differentiate fat necrosis from
other more worrisome findings within the reconstructed
breast. Fat necrosis is often palpable, however, the differ-
ential diagnosis of a palpable nodule within the reconstructed
breast and/or local changes in the skin adjacent to the
mastectomy site includes fat necrosis, scar tissue, oedema,
fibrocystic disease, seroma, hematoma, suture or dermal
calcifications, abscess, and, more concerning, new or recur-
rent breast cancer. On mammographic examination (Figures
8e10), fat necrosis can present in a variety of different ways,
including a radiolucent mass with a thin wall or with
peripheral calcifications (oil cyst), an irregular area of soft-
tissue density, a spiculated mass, and pleomorphicmicrocalcifications or macrocalcifications [8,9]. Not
surprisingly, fat necrosis is usually located peripherally
where the blood supply is deficient.
On sonographic examination, fat necrosis can appear as
circumscribed anechoic nodules (Figure 11) with or without
posterior acoustic enhancement; however, fat necrosis may
also present with a sonographic appearance similar to complex
cysts (Figure 12), solid mass lesions with ill-defined margins,
or solid mass lesions with well-circumscribed margins [9].
Because fat necrosis is often palpable and manifests as a firm
mass on physical examination, a targeted ultrasound is often
the best approach to provide guidance for image-guided
biopsy.
Various MRI features of fat necrosis (Figures 13e16)
have also been described. These include a solid irregular
mass, with or without a central area of fat intensity, and with
enhancement confined to the extreme periphery of the lesion
or with intense solid-appearing enhancement that simulates
Figure 13. A 54-year-old patient treated with a right mastectomy in 2005, followed by reconstruction with an autologous flap in 2007, and contralateral left
breast reduction in 2008. Routine imaging surveillance with breast magnetic resonance imaging (MRI) demonstrated a 7  6-mm enhancing mass lesion
located laterally in the right breast close to the periphery of the inferior surgical scar. Non-fat-saturated axial T1-weighted images without contrast are seen at
different levels in (A) and (B). Fat-saturated subtracted postcontrast images are seen in (C) and (D). Note the macrocalcifications (void signal) within the right
reconstructed breast and fibrotic bands in the left reduced breast. Second-look ultrasound (E) with fine needle aspiration cytology, demonstrating an oil cyst.
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images [9]. For this reason, good quality nonenhanced
MRI T1-weighted images without fat saturation (Figure 16)
are crucial to identify the presence of the central fat signal
intensity. This key finding allows one to differentiate fat
necrosis from tumour recurrence, because breast cancers do
not contain central fat.
Imaging Features of a Recurrent Cancer in
a Reconstructed Breast
The residual breast tissue that remains after a skin-sparing
mastectomy or modified radical mastectomy has the poten-
tial for cancer recurrence. It is generally accepted that all breast
tissue cannot be excised completely by a mastectomy becausethe tissue is distributed over the anterolateral portion of the
chest wall and axilla [14]. In 1940, Hicken demonstrated why
most mastectomies result in the incomplete removal of the
breast tissue and how breast tissue is spread over the anterior
chest wall. He injected the lactiferous ducts of 17 breasts that
had been excised during a mastectomy to obtain a ‘‘contrast
mammogram.’’ A total of 95% of the images produced showed
ducts passing into the axillary fossa, 15% had extension
downward into the epigastric space, and 2% of the ducts
extended beyond the limits of the latissimus dorsi muscle. In 2
patients, the ducts coursed across the mid sternal line to the
opposite side, although there was no anastomotic communi-
cation noted between the 2 sides [14].
Ongoing surveillance is important to assess for recurrence
after treatment for breast cancer. Routine clinical breast
Figure 14. Magnetic resonance imaging, showing the typical central fat
signal intensity of a mass by using a nonefat-saturated, high-quality T1-
weighted sequence.
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previously had breast cancer. Clinical manifestations of
recurrence may range from palpable nodules to mild skin
thickening or true ‘‘peau d’orange,’’ with orwithout associated
cutaneous erythema.
The use of screening mammography for reconstructed
breasts is still controversial [3,15]. In some institutions, this
procedure is not the standard of care, and, in others, it is routine
for all patients who have skin-sparing mastectomy. The
mammographic presence of a newmass lesion (Figures 17-20)
or malignant-appearing microcalcifications in a reconstructed
breast is highly suggestive of a recurrent disease. Helvie et al
[15] noted that the mammographic appearance of recurrent
carcinoma in TRAM flaps is similar to that of primary breast
cancer.
The ultrasonographic appearance of many recurrences is
also similar to those of primary breast cancer (Figures 19, 20,
22, 23). However, some recurrences show a sonographic
appearance typical of benign lesions, including fat necrosis
(Figure 18) and postoperative fluid collection [9]. Ultrasound-
guided fine-needle biopsy is often a useful method to obtain
samples to prove the pathology diagnosis of a recurrent breast
cancer [9,14,15].
The use of CT for the specific evaluation of recurrence after
TRAM flap reconstruction has also been addressed in the
literature. The thin band that extends to the skin surface on CT
represents the transition from full-thickness TRAMflap skin to
the de-epithelialized skin that is tunneled under the native
chest-wall skin and subcutaneous tissue. Although this bandmay appear thick within a month of surgery, persistent thick-
ening or the development of new thickening should raise
suspicion for infection, inflammation, or recurrent breast
cancer [10]. However, this is a rare finding, and routine follow
up by CT is not recommended. When a soft-tissue mass is
identified on CT within the reconstructed breast (Figures 17,
21, 23), recurrent breast cancer should be strongly suspected,
and mammography and possibly ultrasonography should be
recommended.
Breast cancer recurrence after TRAM flap reconstruction
is relatively rare. The prevalence ranges from 6.7%e10.6%
[14]. Recurrence may occur locally within the reconstructed
breast or in regional lymph nodes. MRI has been reported to
be useful in the evaluation of autogenous tissue flaps because
of its superior resolution of soft-tissue areas [11,14]. On
MRI, tumour recurrence after mastectomy with reconstruc-
tion has been described as a mass with low signal intensity
on T1-weighted images, intermediate signal intensity on
T2-weighted images, and avid and rapid enhancement after
administration of gadolinium contrast material [11]. The
presence of other features, such as rim enhancement and
spiculated margins (Figure 22), increases the likelihood of
malignancy. Imaging surveillance MRI should be recom-
mended primarily for patients at high risk for developing
a recurrence [16,17], including patients who have had
multifocal in situ duct carcinoma or multifocal and/or
multicentric any type of invasive breast cancers and high-risk
patients (BRCA mutation carriers, for example).
The use of MRI in reconstructed autologous flaps in
asymptomatic patients has not been studied. Scaranelo et al [4]
analysed breast implant rupture in a cohort of asymptomatic
patients and did not find recurrent breast cancer in the group of
patients with a silicone implant included to restore the breast
removed after mastectomy. However, this was not the intent of
that prospective evaluation. Current review of our series
suggests that MRI may allow differentiation of benign from
malignant findings in patients after breast reconstruction with
a TRAM flap.
In conclusion, breast reconstruction by using autologous
flaps has increased in popularity. Mammography, ultraso-
nography, CT, and MRI facilitate the visualization of normal
and abnormal findings of the various types of breast recon-
struction methods, including implants, autologous flaps, or
a combination of both. Although these imaging modalities
are available for the evaluation of the reconstructed breasts,
there is no optimal imaging protocol that is recommended for
monitoring the reconstructed breast. Therefore, knowledge
of the spectrum of normal or abnormal imaging features is
required by radiologists.Acknowledgements
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Figure 15. Images of a 58-year-old woman who underwent bilateral mastectomies (left for invasive carcinoma and right for prophylaxis), followed by delayed
reconstruction with transverse rectus abdominus myocutaneous (TRAM) flaps. The patient presented with a firm palpable left breast mass on physical
examination. On sonographic examination, hypoechoic masses are seen in the periphery of the flap (A and B). Fine needle aspiration cytology was done under
sonographic guidance and revealed fat necrosis. Computed tomography, showing rectus muscle atrophy after bilateral breast reconstruction (C) and soft-tissue
masses in the left side, which correspond to the palpable abnormality and biopsy-proven fat necrosis (D).
Figure 16. Right breast reconstruction with autologous transverse rectus abdominus myocutaneous (TRAM) flap in 2002. (A) Postcontrast magnetic resonance
imaging, showing an enhancing nodule in the lateral aspect of the reconstructed breast. (B) Nonenhanced, nonefat-saturated T1-weighted images in the same
plane, showing the fatty nature of the enhancing nodule.
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Figure 17. Computed tomography of a 66-year-old woman 7 years after unilateral breast reconstruction with a pedicle transverse rectus abdominus myocu-
taneous (TRAM) flap, demonstrating a soft-tissue mass lesion (A). Mammography (B) and targeted ultrasound (C) were recommended for further assessment
and demonstrated an ill-defined mass lesion with angulated margins. Ultrasound-guided fine needle aspiration (D), showing the presence of adenocarcinoma.
Figure 18. Ultrasound of a 55-year-old woman 3 years after unilateral reconstruction with pedicle transverse rectus abdominus myocutaneous (TRAM) flap and
a new palpable abnormality detected on breast self examination. (A) Left breast diagnostic ultrasound, showing a hypoechoic superficial palpable mass with
heterogeneous internal echoes. A fine needle aspiration by using a 23-gauge needle was done to rule out recurrence, and a diagnosis of adenocarcinoma was
made. Computed tomography done 1 week later, showing the palpable mass to be located very superficially as a dense circumscribed nodule (arrow) easily
recognizable in the fat-attenuation left reconstructed breast (B).
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Figure 19. Images of a 74-year-old woman with local recurrence in the anterior chest wall after transverse rectus abdominus myocutaneous (TRAM) flap
reconstruction initially detected by breast magnetic resonance imaging. Mammography in the mediolateral oblique view (A) and in the exaggerated lateral
craniocaudal view (B), showing a new density very deep close to the chest wall. Ultrasonography, showing a mass with an irregular shape and spiculated
margins (C).
Figure 20. Images of a 72-year-old woman with local recurrence in the lateral chest wall after transverse rectus abdominus myocutaneous (TRAM) flap
reconstruction detected by palpation on a routine clinical breast examination. Digital mammography in the mediolateral oblique view (A), showing a new
mammographic density (arrow) in the superior breast. Ultrasonography, showing an oval-shaped mass with irregular margins and increased vascularization on
colour Doppler (B).
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Figure 21. Images taken 14 months after bilateral breast reconstruction with autologous transverse rectus abdominus myocutaneous (TRAM) flaps performed
for a left breast invasive multicentric, lobular carcinoma, and right breast prophylaxis. A palpable left breast mass was found on self-breast examination.
Ultrasonography, showing a hypoechoic, almost anechoic, mass lesion highly suspicious for local recurrence (A), which was confirmed by fine needle
aspiration cytology. Computed tomography (CT) of the chest, showing extension of the mass lesion towards the chest wall (B). A sagittal CT reconstructed
image of the palpable mass (arrow) is demonstrated (C).
Figure 22. Images taken 3 years after surgery of a woman who underwent a right mastectomy for extensive invasive lobular carcinoma, followed by
reconstruction with a silicone implant. Screening surveillance with breast magnetic resonance imaging, showing an irregular enhancing mass with spiculated
margins. Axial postcontrast subtracted images (A) and reconstructed images in the sagittal plane (B), showing the close relation of the recurrent cancer with the
breast implant. Digital mammography was not able to demonstrate the mass lesion (C). Ultrasonography was used, and an irregular hypoechoic mass with
a surrounding echogenic rim was identified (D). An ultrasound-guided biopsy was performed to prove local recurrence.
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Figure 23. Images of a new palpable mass in a 44-year-old woman who underwent a left mastectomy for multifocal invasive ductal carcinoma and breast
reconstruction with a silicone implant. Ultrasonography showed an irregular mass (A), which was proven to be adenocarcinoma on biopsy. Digital
mammography did not show the mass lesion. A reconstructed computed tomography image in the sagittal plane was able to demonstrate (arrow) the new mass
lesion (B).
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